STOCK TITAN

Amdocs officer Rajat Raheja sells 3,701 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4/A

Rhea-AI Filing Summary

Amdocs Ltd (DOX) officer Rajat Raheja reported 3,701 ordinary shares acquired upon RSU vesting and sold between November 10 and November 15, 2026. Sales were at $42.18 per share on November 10, $43.14 on November 11, and $43.34 on November 14 and 15; no Rule 10b5-1 plan is reported. The amendment corrects derivative securities beneficially owned after vesting to 0, rather than the previously reported 5,503. It also reports 2,340 performance stock units, subject to vesting in substantially equal installments on November 14, 2026, November 14, 2027, and November 14, 2028.

Insider Raheja Rajat
Role See Remarks
Sold 3,701 shs ($159K)
Approx. gross sale proceeds $159K
Share of Position Sold 100%
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F8 350 $0.00 $0.00
Exercise Restricted Stock Units F1, F9 701 $0.00 $0.00
Exercise Ordinary Shares F1 350 -- --
Sale Ordinary Shares 350 $43.34 $15K
Exercise Ordinary Shares F1 701 -- --
Sale Ordinary Shares 701 $43.34 $30K
Exercise Restricted Stock Units F1, F7 390 $0.00 $0.00
Exercise Restricted Stock Units F1, F5 780 $0.00 $0.00
Exercise Ordinary Shares F1 390 -- --
Sale Ordinary Shares 390 $43.34 $17K
Exercise Ordinary Shares F1 780 -- --
Sale Ordinary Shares 780 $43.34 $34K
Exercise Restricted Stock Units F6, F1, F4 360 $0.00 $0.00
Exercise Ordinary Shares F1 360 -- --
Sale Ordinary Shares 360 $43.14 $16K
Exercise Restricted Stock Units F1, F2 374 $0.00 $0.00
Exercise Restricted Stock Units F1, F3 746 $0.00 $0.00
Exercise Ordinary Shares F1 374 -- --
Sale Ordinary Shares 374 $42.18 $16K
Exercise Ordinary Shares F1 746 -- --
Sale Ordinary Shares 746 $42.18 $31K
Grant/Award Restricted Stock Units F1, F5 2,340 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 4,502 units (Direct); Ordinary Shares — 0 shares (Direct)
Holdings Before and After: Restricted Stock Units, 5,863 to 4,502 units (Direct); Ordinary Shares, 0 to 0 shares (Direct)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (9)
  1. F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share of the Issuer.
  2. F2. The RSUs vested with respect to 374 Ordinary Shares on Nov 10, 2026 and will vest with respect to the remaining 374 Ordinary Shares on Nov 10, 2027.
  3. F3. The RSUs vested in full on Nov 10, 2026
  4. F4. The RSUs vested in full on Nov 11, 2026.
  5. F5. On Nov 14, 2025, the Reporting Person received a grant of Performance Stock Units for which performance was certified on November 3, 2026. The award remains subject to vesting in substantially equal installments on 11/14/2026, 11/14/2027 and 11/14/2028.
  6. F6. On Nov 13, 2026, the Reporting Person filed a Form 4 which inadvertently reported that, following the vesting of these RSUs, the number of derivative securities beneficially owned following the transaction was 5,503. In fact, as reported in this Form 4, the number of derivative securities beneficially owned following the transaction was 0.
  7. F7. The RSUs vested with respect to 390 Ordinary Shares on Nov 14, 2026 and will vest with respect to the remaining 1,170 Ordinary Shares in substantially equal installments on Nov 14, 2027, Nov 14, 2028 and Nov 14, 2029.
  8. F8. The RSUs vested with respect to 350 Ordinary Shares on Nov 15, 2026 and will vest with respect to the remaining 700 Ordinary Shares in substantially equal installments on Nov 15, 2027 and Nov 15, 2028
  9. F9. The RSUs vested with respect to 701 Ordinary Shares on Nov 15, 2026 and will vest with respect to the remaining 698 Ordinary Shares on Nov 15, 2027
Shares sold 3,701 ordinary shares Reported sales from November 10, 2026, through November 15, 2026.
Sale price per share $42.18 per share Sales on November 10, 2026.
Sale price per share $43.14 per share Sales on November 11, 2026.
Sale price per share $43.34 per share Sales on November 14 and November 15, 2026.
Derivative securities beneficially owned after vesting 0 securities Corrected post-vesting amount stated in the amendment.
Previously reported derivative securities beneficially owned 5,503 securities Prior post-vesting amount identified as inadvertently reported and corrected to 0.
Performance Stock Units 2,340 units Award received November 14, 2025; performance certified November 3, 2026, with vesting scheduled on November 14, 2026, November 14, 2027, and November 14, 2028.
Restricted Stock Unit financial
"Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Performance Stock Units financial
"received a grant of Performance Stock Units for which performance was certified"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
beneficially owned regulatory
"number of derivative securities beneficially owned following the transaction was 0"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DOX shares did Rajat Raheja sell, and at what prices?

Rajat Raheja sold 3,701 ordinary shares in transactions dated November 10, 2026, November 11, 2026, November 14, 2026, and November 15, 2026. Prices were $42.18 per share on November 10, 2026, $43.14 on November 11, 2026, and $43.34 on November 14 and 15, 2026. No Rule 10b5-1 plan is reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Raheja Rajat

(Last)(First)(Middle)
C/O AMDOCS INC
631 MARYVILLE CENTRE DRIVE, SUITE 200

(Street)
SAINT LOUIS MISSOURI 63141

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AMDOCS LTD [ DOX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
11/13/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares11/10/2026M374A(1)374D
Ordinary Shares11/10/2026S374D$42.180D
Ordinary Shares11/10/2026M746A(1)746D
Ordinary Shares11/10/2026S746D$42.180D
Ordinary Shares11/11/2026M360A(1)360D
Ordinary Shares11/11/2026S360D$43.140D
Ordinary Shares11/14/2026M390A(1)390D
Ordinary Shares11/14/2026S390D$43.340D
Ordinary Shares11/14/2026M780A(1)780D
Ordinary Shares11/14/2026S780D$43.340D
Ordinary Shares11/15/2026M350A(1)350D
Ordinary Shares11/15/2026S350D$43.340D
Ordinary Shares11/15/2026M701A(1)701D
Ordinary Shares11/15/2026S701D$43.340D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)11/10/2026M374 (2) (2)Ordinary Shares374$0374D
Restricted Stock Units(1)11/10/2026M746 (3) (3)Ordinary Shares746$00D
Restricted Stock Units(6)(1)11/11/2026M360 (4) (4)Ordinary Shares360$00(6)D
Restricted Stock Units(1)11/03/2026A2,340 (5) (5)Ordinary Shares2,340$02,340D
Restricted Stock Units(1)11/14/2026M390 (7) (7)Ordinary Shares390$01,170D
Restricted Stock Units(1)11/14/2026M780 (5) (5)Ordinary Shares780$01,560D
Restricted Stock Units(1)11/15/2026M350 (8) (8)Ordinary Shares350$0700D
Restricted Stock Units(1)11/15/2026M701 (9) (9)Ordinary Shares701$0698D
Explanation of Responses:
1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share of the Issuer.
2. The RSUs vested with respect to 374 Ordinary Shares on Nov 10, 2026 and will vest with respect to the remaining 374 Ordinary Shares on Nov 10, 2027.
3. The RSUs vested in full on Nov 10, 2026
4. The RSUs vested in full on Nov 11, 2026.
5. On Nov 14, 2025, the Reporting Person received a grant of Performance Stock Units for which performance was certified on November 3, 2026. The award remains subject to vesting in substantially equal installments on 11/14/2026, 11/14/2027 and 11/14/2028.
6. On Nov 13, 2026, the Reporting Person filed a Form 4 which inadvertently reported that, following the vesting of these RSUs, the number of derivative securities beneficially owned following the transaction was 5,503. In fact, as reported in this Form 4, the number of derivative securities beneficially owned following the transaction was 0.
7. The RSUs vested with respect to 390 Ordinary Shares on Nov 14, 2026 and will vest with respect to the remaining 1,170 Ordinary Shares in substantially equal installments on Nov 14, 2027, Nov 14, 2028 and Nov 14, 2029.
8. The RSUs vested with respect to 350 Ordinary Shares on Nov 15, 2026 and will vest with respect to the remaining 700 Ordinary Shares in substantially equal installments on Nov 15, 2027 and Nov 15, 2028
9. The RSUs vested with respect to 701 Ordinary Shares on Nov 15, 2026 and will vest with respect to the remaining 698 Ordinary Shares on Nov 15, 2027
/s/ Raheja Rajat11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading